Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
暂无分享，去创建一个
Xiaohong Yan | R. Elashoff | M. Roth | M. Mayes | J. Golden | C. Strange | C. Read | D. Furst | R. Simms | J. Varga | D. Khanna | R. Wise | V. Steen | P. Clements | J. Seibold | B. Fessler | V. Hsu | R. Silver | M. Olman | A. Theodore | M. Bolster | D. Tashkin | B. White | M. Metersky | F. Wigley | N. Rothfield | D. Schraufnagel | K. Mubarak | D. J. Riley | Michael D. Roth | E. Parsley | D. Furst | M. K. Connolly | D. Riley | M. Connolly | David J. Riley | Dean E. Schraufnagel | M. Kari Connolly